PART I General Elite Pharmaceuticals, Inc., a Nevada corporation (the Company, Elite, Elite Pharmaceuticals, the registrant, we, us or our) was incorporated on October 1, 1997 under the laws of the State of Delaware, and its wholly-owned subsidiary, Elite Laboratories, Inc. (Elite Labs), was incorporated on August 23, 1990 under the laws of the State of Delaware. On January 5, 2012, Elite Pharmaceuticals was reincorporated under the laws of the State of Nevada. We are a specialty pharmaceutical ...
Q2 FY2026 — expected 2026-08-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-06-30 | 2025-03-31 | 0001641172-25-017134 | EDGAR | 77K words |
| 2024-07-01 | 2024-03-31 | 0001493152-24-025829 | EDGAR | — |
| 2023-06-29 | 2023-03-31 | 0001493152-23-022936 | EDGAR | — |
| 2022-06-29 | 2022-03-31 | 0001493152-22-018108 | EDGAR | — |
| 2021-06-14 | 2021-03-31 | 0001213900-21-032329 | EDGAR | — |
| 2020-06-29 | 2020-03-31 | 0001213900-20-016181 | EDGAR | — |
| 2019-06-21 | 2019-03-31 | 0001213900-19-011224 | EDGAR | — |
| 2018-06-14 | 2018-03-31 | 0001144204-18-034237 | EDGAR | — |
| 2017-06-14 | 2017-03-31 | 0001144204-17-032547 | EDGAR | — |
| 2016-06-15 | 2016-03-31 | 0001144204-16-108327 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001493152-26-007104 | EDGAR | 27K words |
| 2025-11-14 | 2025-09-30 | 0001493152-25-023477 | EDGAR | — |
| 2025-08-14 | 2025-06-30 | 0001493152-25-011989 | EDGAR | — |
| 2025-02-13 | 2024-12-31 | 0001493152-25-006427 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001493152-24-045933 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001493152-24-032154 | EDGAR | — |
| 2024-02-14 | 2023-12-31 | 0001493152-24-006661 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001493152-23-041124 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028434 | EDGAR | — |
| 2023-02-14 | 2022-12-31 | 0001493152-23-004896 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-032117 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001493152-22-022928 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001493152-26-014813 | EDGAR | 1K words |
| 2026-02-17 | 0001493152-26-007190 | EDGAR | — |
| 2026-02-11 | 0001493152-26-006213 | EDGAR | — |
| 2025-11-14 | 0001493152-25-023629 | EDGAR | — |
| 2025-11-12 | 0001493152-25-021717 | EDGAR | — |
| 2025-11-10 | 0001493152-25-021392 | EDGAR | — |
| 2025-08-14 | 0001641172-25-024088 | EDGAR | — |
| 2025-08-08 | 0001493152-25-011765 | EDGAR | — |
| 2025-06-30 | 0001641172-25-017151 | EDGAR | — |
| 2025-06-23 | 0001641172-25-016000 | EDGAR | — |
398 total filings indexed. 366 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001053369 |
| Ticker | ELTP |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NJ |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report